Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update. (2021)

Peer-Reviewed Study · Jong-Yil Chai; Bong-Kwang Jung; Sung-Jong Hong · June 2021

Jong-Yil Chai et al., 2021-06: Update review of albendazole and mebendazole as antiparasitic and anticancer agents, from the Korean parasitology literature.

These drugs are known to block the microtubule systems of parasites and mammalian cells leading to inhibition of glucose uptake and transport and finally cell death.

Jong-Yil Chai et al., 2021-06: Update review of albendazole and mebendazole as antiparasitic and anticancer agents, from the Korean parasitology literature. Study type: review. N: not applicable. Country: Korea (Institute of Parasitic Diseases, Seoul). Dose: not applicable. Funder: not stated in the record. Declared conflicts: 'We have no conflict of interest related to this study.' Product: none. Comparator: not applicable.